HEPATO PROTECTIVE EFFICACY OF TERMINALIA CHEBULA, TERMINALIA BELLIRICA, PHYLLANTHUS EMBLICA AND THEIR FORMULATION ON IMIDACLOPRID INDUCED LIVER TOXICITY BY HISTOPATHOLOGICAL AND BIOCHEMICAL PARAMETERS
Journal Title: International Journal of Pharmaceutical Sciences and Drug Research - Year 2015, Vol 7, Issue 5
Abstract
Terminalia chebula, Terminalia bellirica, Phyllanthus emblica and their formulations are used as a phytotherapeutic medicine for hepatic diseases. In the present study the effect of methanolic extract of herbal powder was administered against Imidacloprid in Albino Wistar Rats. Single dose of herbal (500 mg/kg/b.w) was given orally for 28 days to Imidacloprid toxicity exposed to rats. They were observed each hour and each day for 28 days for any changes in behavioural activity loss of ability to move, cramping, lethargy, muscle weakness, convulsion, irritation of the eye, excess salivation, change in gait. Clinical observations body weight, organ weight, biochemical analysis and histopathological examination were carried out. Administration of Imidacloprid, produced liver degeneration such as cytoplasmic vacuolation, mild vacuolar degeneration, mild hepatic damage in low dose (40 mg/kg b.w) and appearance of blood streaks, hepatic damage and severe vacuolar degenerations were observed in high dose of induction (80 mg/kg b.w). Animals were treated with the phytotherapeutic products of Terminalia chebula, Terminalia bellirica, Phyllanthus emblica and their formulations. Triphala extract was possessed more hepatoprotective activity, while comparing the four samples which was proved experimentally.
Authors and Affiliations
V. Eugin Amala, M. Jeyaraj
DEVELOPMENT AND EVALUATION OF MULTILAYERED LAYERED MATRIX TABLETS OF WATER SOLUBLE DRUG
A new approach to zero- order drug delivery that includes geometric factors is described. Systems such as multilayered tablets and other geometrically altered devices have been created to perform this function. The multi...
SAFETY, TOLERABILITY AND BIOEQUIVALENCE ASSESSMENT OF A DISPERSIBLE TABLET FORMULATION OF PYRAZINAMIDE
Pyrazinamide is a widely used drug for the treatment of tuberculosis. A 150 mg Dispersible Tablet (DT) formulation of the drug was prepared by Micro Labs, a generic drug company. The formulation was developed for easy ad...
EVALUATION OF EFFICACY AND SAFETY OF ARTEMISININ DERIVATIVES FOR TREATMENT OF SEVERE MALARIA: A META-ANALYSIS APPROACH
Despite progress in antimalarial management and intensive care, the prevalence of malaria is growing and the mortality rate is very high. Yet even with timely treatment of quinine in maximum doses, the death in patients...
EVALUATION OF EXTRACTS OF QUALEA PARAENSIS DUCKE FOR THEIR ANTIMICROBIAL, TOXIC AND ANTICHOLINESTERASE ACTIVITIES
Popularly known as red mandioqueira, ‘mandioqueira vermelha’, Qualea paraensis Ducke is a plant species belonging to the family Vochysiaceae, with a natural distribution in the Amazon region. It is used in traditional me...
DEVELOPMENT AND VALIDATION OF CHEMOMETRIC ASSISTED SPECTROPHOTOMETRIC TECHNIQUE FOR SIMULTANEOUS ESTIMATION OF CINITAPRIDE AND PANTOPRAZOLE FROM BULK AND COMBINED DOSAGE FORM
This paper describes two sensitive, accurate and precise chemometric spectrophotometric methods for the simultaneous determination of Cinitapride hydrogen tartarate (CNT) and Pantoprazole sodium (PANTO) in bulk powder an...